Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2019-12-13
Summary
Acquired dysfunctional immunity in cirrhosis predisposes patients to frequent bacterial infections contributing to disease progression and may lead to the development of acute-on-chronic liver failure (ACLF). Spontaneous bacterial peritonitis (SBP) is one of the most frequent infections in cirrhosis and therefore a trigger for ACLF. ACLF is characterized by systemic inflammation even in the absence of confirmed infection and associated with poor outcome. The source of ascites infection, especially in case of culture-positive SBP and bacterascites, is suspected to be bacterial translocation from gut.
In decompensated cirrhosis, data on the gut microbial translocation in different circulatory compartments is limited. Moreover, the link between gut microbiome and systemic inflammation in liver disease has still not established.
The transjugular intrahepatic portosystemic shunt (TIPS) is applied to treat portal hypertension which frequently leads to intestinal bleeding, life-threatening esophageal bleeding and ascites. Under the procedure of TIPS, the vein blood samples in different compartments (superior mesenteric vein, portal vein and hepatic vein) from patients with decompensated liver cirrhosis are available. Metagenomic next-generation sequencing (mNGS) is a promise approach for the diagnosis of infectious disease because a comprehensive spectrum of potential causes (viral, bacterial, fungal, and parasitic) can be identified by a single assay. Previous study reported that mNGS of cerebrospinal fluid can be applied to diagnosis of meningitis and encephalitis. Comparing to traditional bacterial culture method, mNGS method is more sensitive and rapidly in pathogen detection. Therefore, the circulating microbiome in different compartment can be characterized by means of mNGS.
Here, the study aim to investigate the circulating microbiome from superior mesenteric vein (first venous outflow in gut-liver axis), hepatic vein (liver outflow), peripheral vein and ascites from patients with decompensated liver cirrhosis receiving TIPS. Before TIPS, fecal sample and unary sample are collected. And mNGS method is performed to identify the pathogen in ascites,fecal and blood samples in a single center. Ultimately, the study aim to build up the link between gut microbiome translocation and liver disease.
Conditions
- Cirrhosis, Liver
Interventions
- OTHER
-
mNGS for pathogen detection
mNGS for pathogen detection and metabonomics (ascites, fecal,venous blood from superior mesenteric vein, hepatic vein and peripheral vein, respectively)
Sponsors & Collaborators
-
Nanfang Hospital, Southern Medical University
lead OTHER
Principal Investigators
-
Jinjun Chen · Nanfang Hospital, Southern Medical University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-28
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Gut Mycobiome Profile in Alcoholic Liver Disease.
NCT05793190 ·Status: UNKNOWN
-
Study and Analysis of Acute Pancreatitis Complicated With COVID-19
NCT05722678 ·Status: UNKNOWN
-
Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
NCT05641025 ·Status: COMPLETED
-
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580 ·Status: RECRUITING
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
NCT04587323 ·Status: COMPLETED
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Autoimmune Hepatitis Cohort in China
NCT05785793 ·Status: RECRUITING
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED
-
Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections
NCT06774638 ·Status: COMPLETED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Characterization of the Immunometabolic Signature in Long COVID-19.
NCT05758480 ·Status: COMPLETED ·Phase: NA
-
Predictors of Spontaneous Bacterial Peritonitis Among Patients with Cirrhosis
NCT06884306 ·Status: NOT_YET_RECRUITING
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Study of the Clinical Features of Autoimmune Hepatitis
NCT02994537 ·Status: UNKNOWN
-
CMV Reactivation in Acute Necrotizing Pancreatitis
NCT05898048 ·Status: COMPLETED
-
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
NCT07238114 ·Status: ACTIVE_NOT_RECRUITING
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
Intestinal Barrier Function and Liver Cirrhosis
NCT01081236 ·Status: UNKNOWN
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
The Role of Immune Semaphorins in NAFLD
NCT04573543 ·Status: COMPLETED
-
Role of Coagulation, Inflammation and Vessels in Chronic Liver Disease
NCT05865691 ·Status: RECRUITING
-
French National MICMAF Cohort
NCT05895890 ·Status: RECRUITING